NEW YORK: US stocks ended lower on Friday, dragged down by a sharp fall in drugmaker Merck & Co Inc on concerns about a key drug, worries ahead of the Iraq election and weaker-than-expected economic growth.
Dow component Merck tumbled more than 10% as it said a federal judge ruled that its second-biggest product, the osteoporosis drug Fosamax, will lose its US patent protection 10 years earlier than expected.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!